Elena Viboch, partner at General Catalyst, discusses her predictions for biotech and health tech investing and how startups can grow in a more constrained economic environment. Viboch said startups need to focus on the end goal — building technology or therapies that can help patients, Mobi Health News reports.
She said, “
I think on the digital health side, COVID was such an incredible tailwind that people are recalibrating. What are the changes that are here to stay, and what were temporary changes in behavior? Probably the easiest example is we looked at a lot of companies that had COVID diagnostics and didn’t invest because it was a super important problem but it’s kind of a peak and trough unless you have a generalized roadmap. Where are you going? What are you going to do from there? So, those are the kinds of companies that really have suffered, versus sustaining companies or enduring companies.”
